Capital Innovations’s Xylem XYL Stock Holding History

Capital Innovations’s Portfolio XYL Stock Details XYL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-34,513	Closed	-$4.7M	–	101
2025 Q4	$4.7M	Buy	+34,513	New	+$4.96M	1.34%	27

Other funds holding XYL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Capital Innovations's XYL Position: Q1 2026 in Review

Capital Innovations sold out of Xylem (XYL) in Q1 2026, closing a stake of 34,513 shares — an estimated $4.7M sold.

Capital Innovations first reported a position in XYL in Q4 2025 and held it in 1 quarter. The position peaked at $4.7M in Q4 2025. 1,109 funds tracked by Wall St. Rank hold XYL as of Q1 2026.

Capital Innovations reported no remaining Xylem position as of Q1 2026 after selling out during the quarter.
Capital Innovations sold 34,513 Xylem shares in Q1 2026, an estimated $4.7M.
Capital Innovations first reported a position in Xylem in Q4 2025 and held it in 1 quarter.
Capital Innovations's Xylem position peaked at $4.7M in Q4 2025.
1,109 funds tracked by Wall St. Rank held Xylem as of Q1 2026.

Based on Capital Innovations's 13F filing for Q1 2026, filed 14 May 2026.